Letter regarding article by Ridker et al, "Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?". [electronic resource]
- Circulation Dec 2004
- e532 p. digital
Publication Type: Letter; Comment
1524-4539
10.1161/01.CIR.0000149807.32506.F4 doi
C-Reactive Protein--analysis Cardiovascular Diseases--blood Humans Metabolic Syndrome--blood Predictive Value of Tests Risk Assessment Risk Factors